Previous Article | Next Article ![]()
Infection and Immunity, June 2000, p. 3290-3296, Vol. 68, No. 6
Department of Biomedical Sciences and
Pathobiology, Center for Molecular Medicine and Infectious
Diseases, Virginia-Maryland Regional College of Veterinary
Medicine, Virginia Polytechnic Institute and State University,
Blacksburg, Virginia 24061-0342
Received 9 December 1999/Returned for modification 28 February
2000/Accepted 22 March 2000
Brucella abortus strain RB51 is a stable, rough,
attenuated mutant widely used as a live vaccine for bovine brucellosis.
Our ultimate goal is to develop strain RB51 as a preferential vector for the delivery of protective antigens of other intracellular pathogens to which the induction of a strong Th1 type of immune response is needed for effective protection. As a first step in that
direction, we studied the expression of a foreign reporter protein,
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Brucella abortus Strain RB51 as a Vector for
Heterologous Protein Expression and Induction of Specific Th1 Type
Immune Responses
-galactosidase of Escherichia coli, and the 65-kDa heat shock protein (HSP65) of Mycobacterium bovis in strain
RB51. We cloned the promoter sequences of Brucella sodC and
groE genes in pBBR1MCS to generate plasmids pBBSODpro and
pBBgroE, respectively. The genes for
-galactosidase
(lacZ) and HSP65 were cloned in these plasmids and used to
transform strain RB51. An enzyme assay in the recombinant RB51 strains
indicated that the level of
-galactosidase expression is higher
under the groE promoter than under the sodC promoter. In strain RB51 containing pBBgroE/lacZ, but not
pBBSODpro/lacZ, increased levels of
-galactosidase expression were
observed after subjecting the bacteria to heat shock or following
internalization into macrophage-like J774A.1 cells. Mice vaccinated
with either of the
-galactosidase-expressing recombinant RB51
strains developed specific antibodies of predominantly the
immunoglobulin G2a (IgG2a) isotype, and in vitro stimulation of their
splenocytes with
-galactosidase induced the secretion of gamma
interferon (IFN-
), but not interleukin-4 (IL-4). A Th1 type of
immune response to HSP65, as indicated by the presence of specific
serum IgG2a, but not IgG1, antibodies, and IFN-
, but not IL-4,
secretion by the specific-antigen-stimulated splenocytes, was also
detected in mice vaccinated with strain RB51 containing pBBgroE/hsp65.
Studies with mice indicated that expression of
-galactosidase or
HSP65 did not alter either the attenuation characteristics of strain
RB51 or its vaccine efficacy against B. abortus 2308 challenge.
*
Corresponding author. Mailing address: Center for
Molecular Medicine and Infectious Diseases, 1410 Prices
Fork Rd., Blacksburg, VA 24061. Phone: (540) 231-7757. Fax: (540)
231-3426. E-mail: rvemulap{at}vt.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»